Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral vaccine
|
| gptkbp:age |
2 years and older
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:World_Health_Organization 1991 |
| gptkbp:ATCCode |
gptkb:J07AE01
|
| gptkbp:broadcastOn |
2 doses for adults
3 doses for children 2-6 years |
| gptkbp:contains |
inactivated Vibrio cholerae O1
recombinant cholera toxin B-subunit |
| gptkbp:contraindication |
hypersensitivity to any component
|
| gptkbp:form |
suspension for oral administration
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dukoral
|
| gptkbp:manufacturer |
gptkb:Valneva
|
| gptkbp:notRecommendedFor |
treatment of ETEC diarrhea
treatment of cholera |
| gptkbp:protectionDuration |
up to 2 years for cholera
up to 3 months for ETEC |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fever
nausea diarrhea abdominal pain mild gastrointestinal symptoms |
| gptkbp:storage |
refrigerated (2-8°C)
|
| gptkbp:usedFor |
prevention of cholera
prevention of enterotoxigenic Escherichia coli (ETEC) diarrhea |
| gptkbp:bfsParent |
gptkb:cholera_vaccine
|
| gptkbp:bfsLayer |
6
|